Scientech Research LLC’s ResMed RMD Stock Holding History

Scientech Research LLC’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,089	Closed	-$298K	–	757
2025 Q3	$298K	Buy	+1,089	New	+$297K	0.1%	378
2024 Q4	–	Sell	-6,718	Closed	-$1.64M	–	814
2024 Q3	$1.64M	Buy	+6,718	New	+$1.5M	0.33%	68

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Scientech Research LLC's RMD Position: Q4 2025 in Review

Scientech Research LLC sold out of ResMed (RMD) in Q4 2025, closing a stake of 1,089 shares — an estimated $298K sold.

Scientech Research LLC first reported a position in RMD in Q3 2024 and held it in 2 quarters. The position peaked at $1.64M in Q3 2024. 947 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

Scientech Research LLC reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
Scientech Research LLC sold 1,089 ResMed shares in Q4 2025, an estimated $298K.
Scientech Research LLC first reported a position in ResMed in Q3 2024 and held it in 2 quarters.
Scientech Research LLC's ResMed position peaked at $1.64M in Q3 2024.
947 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Scientech Research LLC's 13F filing for Q4 2025, filed 17 Feb 2026.